comparemela.com

Latest Breaking News On - Income announces - Page 1 : comparemela.com

JPMorgan Multi-Asset Growth & Income (LON:MATE) Trading 1 3% Higher

JPMorgan Multi-Asset Growth & Income (LON:MATE – Get Free Report) traded up 1.3% during trading on Thursday . The company traded as high as GBX 99.25 ($1.26) and last traded at GBX 99.25 ($1.26). 67,006 shares were traded during mid-day trading, a decline of 16% from the average session volume of 80,232 shares. The stock […]

JPMorgan European Growth & Income (LON:JEGI) Insider Andrew Robson Acquires 25,000 Shares

JPMorgan European Growth & Income (LON:JEGI – Get Free Report) insider Andrew Robson purchased 25,000 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was acquired at an average price of GBX 99 ($1.24) per share, with a total value of £24,750 ($31,026.70). JPMorgan European Growth & Income Stock Performance […]

JPMorgan Global Growth & Income (LON:JGGI) Sets New 1-Year High at $527 22

JPMorgan Global Growth & Income (LON:JGGI) Sets New 1-Year High at $527 22
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

JPMorgan Global Growth & Income (LON:JGGI) Hits New 1-Year High at $527 22

JPMorgan Global Growth & Income (LON:JGGI) Hits New 1-Year High at $527 22
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

JPMorgan China Growth & Income (LON:JCGI) Sets New 12-Month Low at $189 00

Shares of JPMorgan China Growth & Income (LON:JCGI – Get Free Report) hit a new 52-week low on Monday . The stock traded as low as GBX 189 ($2.40) and last traded at GBX 189.43 ($2.41), with a volume of 423322 shares traded. The stock had previously closed at GBX 196.40 ($2.50). JPMorgan China Growth […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.